Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Kian Behbakht

Concepts (457)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
48
2025
582
5.600
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
11
2025
133
1.620
 Why?
Endometrial Neoplasms
11
2025
196
1.170
 Why?
Drug Resistance, Neoplasm
17
2024
841
1.060
 Why?
Peritoneal Neoplasms
7
2024
102
1.060
 Why?
Cystadenocarcinoma, Serous
7
2025
83
1.010
 Why?
Antineoplastic Combined Chemotherapy Protocols
9
2020
1794
0.870
 Why?
Genital Neoplasms, Female
6
2020
92
0.870
 Why?
Uterine Cervical Neoplasms
8
2017
268
0.860
 Why?
Claudin-4
5
2025
17
0.780
 Why?
Biomarkers, Tumor
9
2025
1248
0.730
 Why?
Hysterectomy
4
2018
137
0.720
 Why?
Neoplasm Recurrence, Local
8
2025
1074
0.710
 Why?
Antineoplastic Agents
10
2023
2163
0.700
 Why?
Fallopian Tube Neoplasms
6
2024
19
0.690
 Why?
TNF-Related Apoptosis-Inducing Ligand
5
2017
51
0.630
 Why?
Gelatin
2
2016
57
0.580
 Why?
Neoplasms, Glandular and Epithelial
3
2015
50
0.560
 Why?
Models, Economic
1
2018
61
0.550
 Why?
Thrombin
2
2016
170
0.550
 Why?
Cell Line, Tumor
22
2025
3504
0.540
 Why?
Hyperthermia, Induced
1
2018
120
0.520
 Why?
Histone-Lysine N-Methyltransferase
3
2024
134
0.520
 Why?
Female
89
2025
75729
0.520
 Why?
Pelvic Infection
1
2016
6
0.500
 Why?
Homeodomain Proteins
3
2012
514
0.490
 Why?
Tissue Adhesives
1
2016
23
0.490
 Why?
Cost-Benefit Analysis
1
2018
612
0.460
 Why?
Neoplastic Cells, Circulating
2
2017
76
0.460
 Why?
Genomic Instability
2
2025
57
0.440
 Why?
Women
1
2015
50
0.440
 Why?
Sirolimus
2
2016
276
0.420
 Why?
Vagina
6
2016
188
0.400
 Why?
Humans
93
2025
141267
0.370
 Why?
Middle Aged
50
2025
34597
0.370
 Why?
Antibodies, Neoplasm
1
2012
33
0.370
 Why?
Health Knowledge, Attitudes, Practice
2
2015
1396
0.360
 Why?
Neoplasm Staging
15
2024
1398
0.350
 Why?
Cisplatin
2
2015
328
0.350
 Why?
Aged
38
2025
24798
0.340
 Why?
Aged, 80 and over
19
2025
7947
0.330
 Why?
Tumor Microenvironment
3
2025
707
0.320
 Why?
Pelvic Exenteration
1
2009
11
0.310
 Why?
Uterine Neoplasms
4
2019
93
0.310
 Why?
Apoptosis
8
2019
2575
0.310
 Why?
Neoadjuvant Therapy
4
2020
427
0.310
 Why?
Leiomyosarcoma
3
2020
29
0.310
 Why?
Paclitaxel
3
2019
235
0.300
 Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
3
2017
30
0.300
 Why?
Robotic Surgical Procedures
3
2016
151
0.300
 Why?
Cytoreduction Surgical Procedures
2
2020
65
0.300
 Why?
Phthalazines
2
2019
63
0.290
 Why?
Pyrimidines
3
2019
511
0.290
 Why?
Health Personnel
1
2015
725
0.280
 Why?
Carcinoma, Endometrioid
3
2019
50
0.280
 Why?
Carbazoles
1
2008
56
0.280
 Why?
Chemotherapy, Adjuvant
2
2020
382
0.280
 Why?
Caffeine
1
2008
74
0.270
 Why?
Azepines
2
2019
98
0.270
 Why?
Gene Expression Regulation, Neoplastic
8
2025
1440
0.270
 Why?
Papanicolaou Test
2
2004
35
0.270
 Why?
Vaginal Smears
2
2004
56
0.260
 Why?
Adult
32
2025
39203
0.260
 Why?
Protein Kinase C
1
2008
252
0.260
 Why?
Clinical Competence
1
2015
1197
0.260
 Why?
Piperazines
2
2019
374
0.250
 Why?
Postoperative Complications
6
2020
2824
0.240
 Why?
Hemostasis, Surgical
2
2016
27
0.230
 Why?
Tumor Escape
1
2025
47
0.230
 Why?
Immune Evasion
1
2025
63
0.230
 Why?
Laparotomy
2
2015
115
0.220
 Why?
Adenocarcinoma
4
2015
896
0.220
 Why?
Urban Health
1
2004
95
0.220
 Why?
Disease-Free Survival
7
2017
714
0.210
 Why?
Fallopian Tubes
1
2024
33
0.210
 Why?
Indoles
2
2025
475
0.210
 Why?
Histocompatibility Antigens
2
2024
108
0.200
 Why?
Prognosis
9
2024
4077
0.200
 Why?
Genetic Therapy
2
2014
316
0.200
 Why?
Pyrazoles
2
2020
482
0.200
 Why?
Uterine Cervical Dysplasia
2
2003
30
0.190
 Why?
Lipids
2
2025
689
0.190
 Why?
Adenocarcinoma, Clear Cell
2
2021
14
0.190
 Why?
Leiomyoma
2
2019
56
0.180
 Why?
Neoplasm Grading
5
2024
309
0.180
 Why?
Radiosurgery
1
2025
389
0.180
 Why?
Hospitals, Public
1
2001
27
0.170
 Why?
Piperidines
2
2019
217
0.170
 Why?
BRCA2 Protein
3
2019
62
0.170
 Why?
Healthcare Disparities
2
2018
674
0.170
 Why?
Hospitals, University
1
2001
176
0.170
 Why?
Vulvar Neoplasms
1
2020
13
0.170
 Why?
Early Detection of Cancer
1
2025
431
0.170
 Why?
Cervix Uteri
3
2011
51
0.160
 Why?
Epoxy Compounds
1
2020
31
0.160
 Why?
Treatment Outcome
11
2020
11194
0.160
 Why?
Mutation
5
2019
4009
0.160
 Why?
Carnitine O-Palmitoyltransferase
1
2020
48
0.160
 Why?
Rad51 Recombinase
1
2019
15
0.160
 Why?
Machine Learning
1
2025
556
0.160
 Why?
Vaccines, Conjugate
1
2019
63
0.150
 Why?
Up-Regulation
2
2020
856
0.150
 Why?
Enoxaparin
1
2020
68
0.150
 Why?
Cell Movement
2
2016
983
0.150
 Why?
Receptors, Adiponectin
1
2019
22
0.150
 Why?
Poly(ADP-ribose) Polymerases
1
2019
100
0.150
 Why?
Animals
15
2025
37642
0.150
 Why?
Neoplasms
4
2017
2731
0.150
 Why?
Interleukin-12
2
2014
123
0.150
 Why?
Pyridones
1
2020
189
0.140
 Why?
Sequence Analysis, RNA
2
2019
450
0.140
 Why?
CD8-Positive T-Lymphocytes
1
2024
916
0.140
 Why?
Mice
11
2025
18092
0.140
 Why?
Lymph Node Excision
2
2020
169
0.140
 Why?
Cancer Vaccines
1
2019
166
0.140
 Why?
Adjuvants, Immunologic
1
2019
238
0.140
 Why?
Ovariectomy
2
2015
158
0.140
 Why?
Cost Savings
1
2018
86
0.140
 Why?
Cell Growth Processes
2
2008
52
0.140
 Why?
Sarcoma
1
2020
193
0.140
 Why?
Oncologists
1
2018
43
0.140
 Why?
Patient Acceptance of Health Care
1
2004
876
0.140
 Why?
Aurora Kinase A
1
2017
56
0.140
 Why?
Dose-Response Relationship, Drug
4
2008
2061
0.130
 Why?
Antineoplastic Agents, Phytogenic
1
2019
192
0.130
 Why?
Breast Neoplasms
4
2019
2247
0.130
 Why?
Pregnancy Complications, Infectious
1
2002
407
0.130
 Why?
Leukocyte Common Antigens
1
2017
90
0.130
 Why?
Anion Transport Proteins
1
2017
8
0.130
 Why?
Salpingectomy
2
2015
15
0.130
 Why?
Sexual Dysfunctions, Psychological
1
2017
30
0.130
 Why?
Survival Rate
5
2020
1973
0.130
 Why?
Gestational Trophoblastic Disease
1
2016
6
0.130
 Why?
Curettage
1
2016
9
0.130
 Why?
Fatty Acids
1
2020
448
0.130
 Why?
beta Catenin
1
2019
258
0.130
 Why?
Keratins
1
2017
171
0.130
 Why?
Megestrol Acetate
1
2016
2
0.120
 Why?
Sexual Dysfunction, Physiological
1
2017
66
0.120
 Why?
Carcinoma, Neuroendocrine
1
2016
34
0.120
 Why?
Minority Groups
1
2018
278
0.120
 Why?
Neoplasms, Squamous Cell
1
1996
4
0.120
 Why?
Colony Count, Microbial
1
2016
123
0.120
 Why?
Standard of Care
1
2016
77
0.120
 Why?
Risk Factors
6
2016
10482
0.120
 Why?
Gynecology
1
2018
178
0.120
 Why?
Medroxyprogesterone Acetate
1
2015
37
0.120
 Why?
Adenoviridae
1
1996
200
0.120
 Why?
Cell Survival
4
2025
1131
0.120
 Why?
Venous Thromboembolism
1
2020
338
0.120
 Why?
Brachytherapy
1
2016
131
0.120
 Why?
Keratin-5
1
2015
48
0.120
 Why?
Gene Expression Profiling
2
2019
1769
0.120
 Why?
Molecular Targeted Therapy
1
2018
420
0.110
 Why?
Tretinoin
1
1996
122
0.110
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2017
985
0.110
 Why?
Tamoxifen
1
2016
203
0.110
 Why?
Immunohistochemistry
3
2016
1726
0.110
 Why?
Chemoradiotherapy
1
2016
232
0.110
 Why?
Combined Modality Therapy
4
2020
1243
0.110
 Why?
Anticoagulants
1
2020
725
0.110
 Why?
Cell Proliferation
5
2024
2504
0.110
 Why?
Antineoplastic Agents, Hormonal
1
2015
170
0.110
 Why?
CA-125 Antigen
2
2008
13
0.110
 Why?
Abdominal Abscess
1
2014
25
0.110
 Why?
Mice, SCID
2
2012
367
0.110
 Why?
Xenograft Model Antitumor Assays
3
2024
917
0.100
 Why?
Kaplan-Meier Estimate
4
2020
912
0.100
 Why?
Endometrium
1
2014
62
0.100
 Why?
Glycoproteins
1
2015
358
0.100
 Why?
Cytokines
1
2002
2093
0.100
 Why?
Surgeons
1
2018
335
0.100
 Why?
Lipid Metabolism
1
2017
525
0.100
 Why?
Reoperation
1
2016
593
0.100
 Why?
Immunotherapy
1
2018
644
0.100
 Why?
Interpersonal Relations
1
2017
407
0.100
 Why?
Cell Cycle
2
2025
601
0.100
 Why?
Double-Blind Method
4
2025
1980
0.100
 Why?
Case-Control Studies
5
2025
3580
0.100
 Why?
Quality of Health Care
1
2018
647
0.100
 Why?
Proto-Oncogene Proteins c-akt
2
2016
442
0.100
 Why?
Transforming Growth Factor beta
1
1996
498
0.100
 Why?
Pelvic Neoplasms
1
2013
25
0.100
 Why?
Genes, Tumor Suppressor
3
1998
84
0.100
 Why?
Plasmids
1
2014
366
0.100
 Why?
Models, Biological
3
2019
1826
0.100
 Why?
Antigens, CD
1
2015
544
0.100
 Why?
Young Adult
5
2020
13667
0.100
 Why?
Gardnerella vaginalis
2
2002
3
0.090
 Why?
Antibody Specificity
1
2012
187
0.090
 Why?
RNA, Messenger
2
2012
2826
0.090
 Why?
Cell Division
2
2008
793
0.090
 Why?
Endocrine Gland Neoplasms
1
2011
1
0.090
 Why?
Escherichia coli
1
2016
836
0.090
 Why?
Transplantation, Heterologous
1
2012
194
0.090
 Why?
Neoplastic Stem Cells
1
2015
411
0.090
 Why?
RNA, Small Interfering
3
2020
628
0.090
 Why?
Cyclin D1
1
2011
68
0.090
 Why?
Drug Synergism
2
2011
370
0.090
 Why?
Proteasome Inhibitors
1
2011
42
0.090
 Why?
MicroRNAs
1
2017
694
0.080
 Why?
DNA
1
2017
1441
0.080
 Why?
Adenocarcinoma, Mucinous
1
2011
76
0.080
 Why?
Transfection
2
2007
936
0.080
 Why?
Peptides
1
2015
981
0.080
 Why?
Cadherins
1
2011
201
0.080
 Why?
Neoplasm Invasiveness
3
2016
509
0.080
 Why?
Lymphoma
1
2011
229
0.080
 Why?
Age Factors
5
2016
3292
0.080
 Why?
Inflammation
1
2020
2895
0.070
 Why?
Skin Transplantation
1
2009
85
0.070
 Why?
Anastomosis, Surgical
1
2009
158
0.070
 Why?
Urokinase-Type Plasminogen Activator
1
2008
30
0.070
 Why?
Papillomaviridae
2
2002
121
0.070
 Why?
G2 Phase
1
2008
39
0.070
 Why?
Adaptor Proteins, Signal Transducing
1
2011
439
0.070
 Why?
Adolescent
5
2020
22064
0.070
 Why?
Radiation-Protective Agents
1
2008
26
0.070
 Why?
TOR Serine-Threonine Kinases
1
2011
428
0.070
 Why?
Rectum
1
2009
187
0.070
 Why?
Heterografts
2
2019
135
0.070
 Why?
Genes, BRCA1
2
1998
41
0.070
 Why?
Models, Statistical
1
2011
670
0.070
 Why?
Microsatellite Instability
2
2019
49
0.070
 Why?
Class I Phosphatidylinositol 3-Kinases
2
2019
100
0.070
 Why?
Urinary Bladder
1
2009
195
0.060
 Why?
Cell Culture Techniques
2
2020
368
0.060
 Why?
Cysteine
1
2008
208
0.060
 Why?
Tumor Suppressor Protein p53
3
2019
528
0.060
 Why?
PTEN Phosphohydrolase
2
2019
162
0.060
 Why?
Gynecologic Surgical Procedures
2
2020
66
0.060
 Why?
Adenosarcoma
2
2005
2
0.060
 Why?
Models, Animal
1
2008
393
0.060
 Why?
Proportional Hazards Models
3
2020
1269
0.060
 Why?
Follow-Up Studies
4
2020
5213
0.060
 Why?
Signal Transduction
4
2012
5153
0.060
 Why?
Indazoles
2
2019
76
0.060
 Why?
Maintenance Chemotherapy
1
2025
38
0.060
 Why?
Colposcopy
2
2003
18
0.060
 Why?
Polymerase Chain Reaction
4
2002
1052
0.060
 Why?
Intestinal Neoplasms
1
2005
31
0.060
 Why?
Retrospective Studies
6
2020
16373
0.060
 Why?
Length of Stay
3
2015
1269
0.060
 Why?
Cell Count
2
2015
325
0.060
 Why?
Ovary
1
2007
225
0.060
 Why?
Neoplasm Proteins
3
1998
435
0.060
 Why?
Sexual Behavior
1
2009
493
0.060
 Why?
Germ-Line Mutation
2
1996
168
0.060
 Why?
Ultraviolet Rays
1
2008
401
0.060
 Why?
Chicago
1
2004
62
0.060
 Why?
United States
5
2022
15245
0.050
 Why?
Disease Progression
3
2019
2798
0.050
 Why?
Peptide Fragments
1
2008
699
0.050
 Why?
Tumor Cells, Cultured
2
1996
960
0.050
 Why?
Transcription Factors
4
2011
1707
0.050
 Why?
Antioxidants
1
2008
597
0.050
 Why?
Blood Loss, Surgical
2
2015
112
0.050
 Why?
Survival Analysis
4
2020
1323
0.050
 Why?
Activating Transcription Factor 6
1
2023
20
0.050
 Why?
Receptors, Estrogen
2
2015
411
0.050
 Why?
Transcription Factor AP-1
1
2023
88
0.050
 Why?
X-ray Repair Cross Complementing Protein 1
1
2022
13
0.050
 Why?
Women's Health
1
2004
308
0.050
 Why?
Neoplasm Metastasis
2
2015
676
0.050
 Why?
Trichomonas vaginalis
1
2002
11
0.050
 Why?
Vaginal Neoplasms
1
2001
18
0.050
 Why?
Gene Expression
1
2007
1492
0.050
 Why?
Phosphatidylinositol 3-Kinases
2
2016
369
0.050
 Why?
Yeasts
1
2002
52
0.050
 Why?
Medical Oncology
1
2024
316
0.040
 Why?
Risk Assessment
3
2016
3515
0.040
 Why?
Vaginosis, Bacterial
1
2001
11
0.040
 Why?
Vaginal Diseases
1
2001
19
0.040
 Why?
Cell Nucleus
1
2025
610
0.040
 Why?
Endometriosis
1
2001
57
0.040
 Why?
DNA, Neoplasm
2
1998
159
0.040
 Why?
Quality of Life
2
2025
3021
0.040
 Why?
DNA Primers
1
2002
508
0.040
 Why?
Vulvectomy
1
2020
2
0.040
 Why?
Pregnancy
3
2016
7039
0.040
 Why?
Dermatofibrosarcoma
1
2020
7
0.040
 Why?
Epithelial Cells
1
2007
1114
0.040
 Why?
Histiocytoma, Malignant Fibrous
1
2020
5
0.040
 Why?
Hospitals, Urban
1
2001
137
0.040
 Why?
Clinical Trials, Phase I as Topic
1
2020
53
0.040
 Why?
Disease Models, Animal
2
2024
4413
0.040
 Why?
Liposarcoma
1
2020
30
0.040
 Why?
Medically Uninsured
1
2001
136
0.040
 Why?
Databases, Factual
2
2016
1446
0.040
 Why?
Alleles
3
2017
884
0.040
 Why?
Anoikis
1
2020
31
0.040
 Why?
Hemocyanins
1
2019
61
0.040
 Why?
DNA Repair
1
2022
240
0.040
 Why?
Interleukin-10
1
2002
306
0.040
 Why?
Rhabdomyosarcoma
1
2020
62
0.040
 Why?
Chitinase-3-Like Protein 1
1
2019
19
0.040
 Why?
Diagnosis, Differential
2
2019
1493
0.040
 Why?
Enzyme-Linked Immunosorbent Assay
1
2002
855
0.040
 Why?
Prospective Studies
4
2016
7787
0.040
 Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2019
26
0.040
 Why?
Logistic Models
1
2004
2095
0.040
 Why?
Radiotherapy
1
2020
203
0.040
 Why?
SEER Program
1
2020
219
0.040
 Why?
Intramolecular Oxidoreductases
1
2019
67
0.040
 Why?
DNA Damage
1
2022
430
0.040
 Why?
DNA Polymerase II
1
2019
35
0.040
 Why?
Poly-ADP-Ribose Binding Proteins
1
2019
34
0.040
 Why?
Lymphatic Metastasis
1
2020
326
0.040
 Why?
Chromosomes, Human, Pair 7
1
1998
17
0.040
 Why?
Gene Knockdown Techniques
1
2020
332
0.040
 Why?
Cell Cycle Checkpoints
1
2019
97
0.040
 Why?
Cytoskeletal Proteins
1
2019
156
0.040
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2019
131
0.040
 Why?
Mitosis
1
2019
198
0.030
 Why?
Microtubule-Associated Proteins
1
2019
198
0.030
 Why?
Europe
1
2019
407
0.030
 Why?
Interleukin-1
1
2002
973
0.030
 Why?
AMP-Activated Protein Kinases
1
2019
197
0.030
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
1998
35
0.030
 Why?
Image Cytometry
1
2017
12
0.030
 Why?
Interleukin-6
1
2002
777
0.030
 Why?
Wnt Signaling Pathway
1
2019
203
0.030
 Why?
Chromosomes, Human, Pair 14
1
1997
21
0.030
 Why?
Ganciclovir
1
1996
53
0.030
 Why?
Chromosome Deletion
1
1997
118
0.030
 Why?
Hospitals, Private
1
2016
12
0.030
 Why?
Health Facility Size
1
2016
11
0.030
 Why?
Socioeconomic Factors
1
2001
1312
0.030
 Why?
Chorionic Gonadotropin
1
2016
78
0.030
 Why?
Mass Spectrometry
1
2019
740
0.030
 Why?
Cell Separation
1
2017
317
0.030
 Why?
Oxidation-Reduction
1
2020
1087
0.030
 Why?
Ifosfamide
1
1996
38
0.030
 Why?
Cell Differentiation
2
2011
2001
0.030
 Why?
AC133 Antigen
1
2015
21
0.030
 Why?
Time Factors
2
2019
6971
0.030
 Why?
Cell Line, Transformed
1
1996
145
0.030
 Why?
Tissue Array Analysis
1
2015
51
0.030
 Why?
Hospital Charges
1
1996
44
0.030
 Why?
Hospitals, Teaching
1
2016
115
0.030
 Why?
Marriage
1
2017
123
0.030
 Why?
Caspase 3
1
2016
248
0.030
 Why?
Cystadenocarcinoma, Papillary
1
1995
4
0.030
 Why?
Carboplatin
1
1996
145
0.030
 Why?
Tumor Burden
1
2016
313
0.030
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2015
71
0.030
 Why?
DNA Mismatch Repair
1
2015
48
0.030
 Why?
Ileus
1
2015
13
0.030
 Why?
RNA-Binding Proteins
1
2019
450
0.030
 Why?
Genes, p53
1
1995
68
0.030
 Why?
Cell Cycle Proteins
1
2019
634
0.030
 Why?
Disease Management
1
2019
632
0.030
 Why?
Urinary Retention
1
2015
22
0.030
 Why?
Income
1
2016
198
0.030
 Why?
Female Urogenital Diseases
1
2014
7
0.030
 Why?
RNA Interference
1
2016
468
0.030
 Why?
Taxoids
1
2015
105
0.030
 Why?
Elective Surgical Procedures
1
2016
196
0.030
 Why?
Antigens, Neoplasm
1
2017
324
0.030
 Why?
Multivariate Analysis
2
1996
1505
0.030
 Why?
Morbidity
1
2015
320
0.030
 Why?
Receptors, Androgen
1
2015
153
0.030
 Why?
Drug Administration Schedule
1
2016
773
0.030
 Why?
Reference Values
1
1996
805
0.030
 Why?
Intraoperative Complications
1
2015
147
0.030
 Why?
Blood Volume
1
2014
65
0.030
 Why?
Sensitivity and Specificity
1
2019
1974
0.030
 Why?
Bevacizumab
1
2015
135
0.030
 Why?
Bleomycin
1
1996
248
0.030
 Why?
Point Mutation
1
1995
239
0.030
 Why?
Infusions, Parenteral
1
2014
43
0.030
 Why?
Histones
1
2019
639
0.030
 Why?
Polyethyleneimine
1
2014
18
0.030
 Why?
DNA, Viral
1
1996
363
0.030
 Why?
Hemostatics
1
2014
58
0.030
 Why?
Pelvis
1
2015
116
0.030
 Why?
Receptors, Progesterone
1
2015
337
0.030
 Why?
Tumor Suppressor Proteins
1
2016
325
0.030
 Why?
Insurance, Health
1
2016
298
0.030
 Why?
Deoxycytidine
1
2015
202
0.030
 Why?
Drainage
1
2014
175
0.030
 Why?
Anemia
1
2015
176
0.030
 Why?
Urban Population
1
2016
482
0.020
 Why?
Preoperative Care
1
2015
372
0.020
 Why?
Thrombocytopenia
1
2015
207
0.020
 Why?
Polymorphism, Single-Stranded Conformational
3
1998
25
0.020
 Why?
Gene Transfer Techniques
1
2014
177
0.020
 Why?
Patient Readmission
1
2018
709
0.020
 Why?
Referral and Consultation
1
2018
797
0.020
 Why?
Membrane Proteins
1
2019
1157
0.020
 Why?
Biomarkers
1
2024
4179
0.020
 Why?
Ultrasonography
1
2016
764
0.020
 Why?
Linear Models
1
1994
855
0.020
 Why?
Cholesterol
1
2014
404
0.020
 Why?
Zinc Finger E-box-Binding Homeobox 1
1
2011
24
0.020
 Why?
Analysis of Variance
1
1994
1314
0.020
 Why?
Perioperative Period
1
2011
69
0.020
 Why?
Protein Kinase Inhibitors
1
2017
918
0.020
 Why?
Rural Population
1
2016
605
0.020
 Why?
Mutant Proteins
1
2011
102
0.020
 Why?
DNA Fragmentation
1
2011
41
0.020
 Why?
Risk Reduction Behavior
1
2013
226
0.020
 Why?
Comorbidity
1
2016
1672
0.020
 Why?
Fas Ligand Protein
1
2011
60
0.020
 Why?
Hyperplasia
1
2011
174
0.020
 Why?
Neovascularization, Pathologic
1
2012
295
0.020
 Why?
Neoplasm Transplantation
1
2011
251
0.020
 Why?
Tomography, X-Ray Computed
2
2014
2765
0.020
 Why?
Polymorphism, Single Nucleotide
1
2017
2132
0.020
 Why?
Administration, Oral
1
2012
824
0.020
 Why?
Epithelial-Mesenchymal Transition
1
2011
213
0.020
 Why?
Regression Analysis
1
2011
1015
0.020
 Why?
Pregnancy Complications
1
2014
577
0.020
 Why?
Polyethylene Glycols
1
2014
639
0.020
 Why?
Antibodies, Monoclonal, Humanized
1
2015
911
0.020
 Why?
Anti-Bacterial Agents
2
2014
1865
0.020
 Why?
Receptors, Urokinase Plasminogen Activator
1
2008
15
0.020
 Why?
Blotting, Western
1
2011
1232
0.020
 Why?
Patient Discharge
1
2015
934
0.020
 Why?
Injections, Subcutaneous
1
2008
165
0.020
 Why?
Placebos
1
2008
195
0.020
 Why?
Mice, Hairless
1
2008
59
0.020
 Why?
Enzyme Inhibitors
1
2011
843
0.020
 Why?
Sulfonamides
1
2011
569
0.020
 Why?
Molecular Sequence Data
3
1996
2919
0.020
 Why?
Quality Improvement
1
2015
1239
0.020
 Why?
Chromosome Mapping
2
1998
504
0.020
 Why?
Genetic Markers
2
1998
343
0.020
 Why?
Receptors, Cell Surface
1
2008
398
0.020
 Why?
Frameshift Mutation
2
1996
32
0.020
 Why?
Gene Deletion
2
1998
388
0.010
 Why?
Carcinosarcoma
1
2005
23
0.010
 Why?
Cross-Sectional Studies
1
2017
5653
0.010
 Why?
DNA Mutational Analysis
2
1996
397
0.010
 Why?
Cohort Studies
1
2015
5802
0.010
 Why?
Colorado
1
2014
4599
0.010
 Why?
Severity of Illness Index
1
2011
2905
0.010
 Why?
Obesity
1
2016
3001
0.010
 Why?
Base Sequence
2
1996
2172
0.010
 Why?
Electrophoresis, Gel, Pulsed-Field
1
2001
24
0.010
 Why?
Metronidazole
1
2001
19
0.010
 Why?
Genes, rRNA
1
2001
42
0.010
 Why?
Microbial Sensitivity Tests
1
2001
367
0.010
 Why?
DNA, Bacterial
1
2001
333
0.010
 Why?
RNA, Ribosomal, 16S
1
2001
546
0.010
 Why?
Loss of Heterozygosity
1
1998
51
0.010
 Why?
Microsatellite Repeats
1
1998
159
0.010
 Why?
Actuarial Analysis
1
1996
22
0.010
 Why?
Ecosystem
1
2001
576
0.010
 Why?
Genes, Neoplasm
1
1995
23
0.010
 Why?
BRCA1 Protein
1
1995
78
0.010
 Why?
Sequence Analysis, DNA
1
1998
817
0.010
 Why?
Age of Onset
1
1996
534
0.010
 Why?
Introns
1
1995
253
0.010
 Why?
Exons
1
1995
352
0.010
 Why?
Amino Acid Sequence
1
1995
2153
0.010
 Why?
Male
1
2017
70063
0.010
 Why?
Behbakht's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (457) concept(s)
_
Co-Authors Expand Description
See all (55) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)